Advocate

Country: European Union

Language: Lithuanian

Source: EMA (European Medicines Agency)

Active ingredient:

imidaklopridas, ožkos

Available from:

Bayer Animal Health GmbH

ATC code:

QP54AB52

INN (International Name):

imidacloprid, moxidectin

Therapeutic group:

Dogs; Cats; Ferrets

Therapeutic area:

Nėra vaistai, insekticidai ir repelentai.

Therapeutic indications:

DogsFor šunys kenčia nuo, arba gresia, sumaišyti parazitinės infekcijos:gydymas ir prevencija pchła užkrėtimo (Ctenocephalides felis),gydyti kramtymas utėlių (Trichodectes canis),gydymas, ausų erkės užkrėtimo (Otodectes cynotis), sarcoptic niežų (dėl Sarcoptes scabiei var. canis), demodicosis (dėl Demodex canis),prevencijos heartworm ligos (L3 ir L4 lervos, Dirofilaria immitis),gydymo cirkuliuojančių microfilariae (Dirofilaria immitis),gydyti odos dirofilariosis (suaugusiųjų etapais Dirofilaria repens)prevencijos odos dirofilariosis (L3 lervų Dirofilaria repens),sumažinti cirkuliuojančio microfilariae (Dirofilaria repens),prevencijos angiostrongylosis (L4 lervų ir nesubrendęs suaugusiems Angiostrongylus vasorum),gydymo Angiostrongylus vasorum ir Crenosoma vulpis,prevencijos spirocercosis (Spirocerca lupi),gydymo Eucoleus (syn. Capillaria) boehmi (suaugusiems),gydymas, akių širdys Thelazia callipaeda (suaugusiems),gydyti infekcijos virškinimo trakto nematodų (L4 lervų, nesubrendęs suaugusiųjų ir suaugusiems Toxocara canis, Ancylostoma caninum ir Uncinaria stenocephala, suaugusiems Toxascaris leonina ir Trichuris vulpis). Produktas gali būti naudojamas kaip blusų alerginio dermatito (FAD) gydymo strategijos dalis.. CatsFor katėms, sergantiems, arba gresia, sumaišyti parazitinės infekcijos:gydymas ir prevencija pchła užkrėtimo (Ctenocephalides felis),gydyti ausų erkės užkrėtimo (Otodectes cynotis),gydymo notoedric niežų (Notoedres cat),gydymo lungworm Eucoleus aerophilus (syn. Capillaria aerophila) (suaugusiems),prevencijos lungworm ligos (L3/L4 lervų Aelurostrongylus abstrusus),gydymo lungworm Aelurostrongylus abstrusus (suaugusiems),gydyti akių širdys Thelazia callipaeda (suaugusiems),prevencijos heartworm ligos (L3 ir L4 lervos, Dirofilaria immitis),gydyti infekcijos virškinimo trakto nematodų (L4 lervų, nesubrendęs suaugusiųjų ir suaugusiems Toxocara cat ir Ancylostoma tubaeforme). Produktas gali būti naudojamas kaip blusų alerginio dermatito (FAD) gydymo strategijos dalis.. FerretsFor šeškus, kenčia nuo, arba gresia, sumaišyti parazitinės infekcijos:gydymas ir prevencija pchła užkrėtimo (Ctenocephalides felis),prevencijos heartworm ligos (L3 ir L4 lervos, Dirofilaria immitis).

Product summary:

Revision: 23

Authorization status:

Įgaliotas

Authorization date:

2003-04-02

Patient Information leaflet

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Naujausia informacija apie šį veterinarinį vaistą pateikiama
veterinarinių vaistų informacijos svetainėje.
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Naujausia informacija apie šį veterinarinį vaistą pateikiama
veterinarinių vaistų informacijos svetainėje.
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Bulgarian 31-01-2024
Public Assessment Report Public Assessment Report Bulgarian 29-01-2024
Patient Information leaflet Patient Information leaflet Spanish 31-01-2024
Public Assessment Report Public Assessment Report Spanish 29-01-2024
Patient Information leaflet Patient Information leaflet Czech 31-01-2024
Public Assessment Report Public Assessment Report Czech 29-01-2024
Patient Information leaflet Patient Information leaflet Danish 31-01-2024
Public Assessment Report Public Assessment Report Danish 29-01-2024
Patient Information leaflet Patient Information leaflet German 31-01-2024
Public Assessment Report Public Assessment Report German 29-01-2024
Patient Information leaflet Patient Information leaflet Estonian 31-01-2024
Public Assessment Report Public Assessment Report Estonian 29-01-2024
Patient Information leaflet Patient Information leaflet Greek 31-01-2024
Public Assessment Report Public Assessment Report Greek 29-01-2024
Patient Information leaflet Patient Information leaflet English 31-01-2024
Public Assessment Report Public Assessment Report English 29-01-2024
Patient Information leaflet Patient Information leaflet French 31-01-2024
Public Assessment Report Public Assessment Report French 29-01-2024
Patient Information leaflet Patient Information leaflet Italian 31-01-2024
Public Assessment Report Public Assessment Report Italian 29-01-2024
Patient Information leaflet Patient Information leaflet Latvian 31-01-2024
Public Assessment Report Public Assessment Report Latvian 29-01-2024
Patient Information leaflet Patient Information leaflet Hungarian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Hungarian 31-01-2024
Public Assessment Report Public Assessment Report Hungarian 29-01-2024
Patient Information leaflet Patient Information leaflet Maltese 31-01-2024
Public Assessment Report Public Assessment Report Maltese 29-01-2024
Patient Information leaflet Patient Information leaflet Dutch 31-01-2024
Public Assessment Report Public Assessment Report Dutch 29-01-2024
Patient Information leaflet Patient Information leaflet Polish 31-01-2024
Public Assessment Report Public Assessment Report Polish 29-01-2024
Patient Information leaflet Patient Information leaflet Portuguese 31-01-2024
Summary of Product characteristics Summary of Product characteristics Portuguese 31-01-2024
Public Assessment Report Public Assessment Report Portuguese 29-01-2024
Patient Information leaflet Patient Information leaflet Romanian 31-01-2024
Public Assessment Report Public Assessment Report Romanian 29-01-2024
Patient Information leaflet Patient Information leaflet Slovak 31-01-2024
Public Assessment Report Public Assessment Report Slovak 29-01-2024
Patient Information leaflet Patient Information leaflet Slovenian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Slovenian 31-01-2024
Public Assessment Report Public Assessment Report Slovenian 29-01-2024
Patient Information leaflet Patient Information leaflet Finnish 31-01-2024
Public Assessment Report Public Assessment Report Finnish 29-01-2024
Patient Information leaflet Patient Information leaflet Swedish 31-01-2024
Public Assessment Report Public Assessment Report Swedish 29-01-2024
Patient Information leaflet Patient Information leaflet Norwegian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Norwegian 31-01-2024
Public Assessment Report Public Assessment Report Norwegian 29-01-2024
Patient Information leaflet Patient Information leaflet Icelandic 31-01-2024
Summary of Product characteristics Summary of Product characteristics Icelandic 31-01-2024
Public Assessment Report Public Assessment Report Icelandic 29-01-2024
Patient Information leaflet Patient Information leaflet Croatian 31-01-2024
Public Assessment Report Public Assessment Report Croatian 29-01-2024

View documents history